CurTec Acquired by Ampersand Capital Partners

Ampersand Capital Partners, a prominent private equity firm with a focus on growth equity investments in the life sciences and healthcare sectors, has acquired CurTec Group B.V., a Netherlands-based manufacturer known for its high-performance plastic packaging solutions tailored to pharmaceutical and specialty chemical industries. With operations in the Netherlands and the U.S., CurTec is renowned for its GMP-compliant, UN-certified packaging integral to the secure handling of high-value biopharmaceutical and chemical substances. Bencis Capital Partners, the previous owner, facilitated the evolution of CurTec into a global leader in regulated packaging through a strong focus on innovation and operational excellence. The strategic acquisition by Ampersand aims to expand CurTec's U.S. operations, bolster product innovation, and widen its market influence. CurTec's newly opened state-of-the-art facility in South Carolina enhances its service capability to the North American market, augmenting its European operations. This acquisition underscores Ampersand's commitment to investing in sustainable and high-growth opportunities within the healthcare supply chain.